Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Krishna R. Kalari, Ph.D., focuses on the development of novel systems pharmacology approaches to investigate cancer genomics. She is actively involved in the development of algorithms and application of computational methods to identify pathways associated with cancer and variation to drug response phenotypes.
The computational methods developed will help researchers and clinicians interpret data to determine functionally relevant loci associated with disease and drug response phenotypes.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.